SCHEMBL23732145

SCHEMBL23732145

CC(C)Oc1cc(CCCN2CCCC2)ccn1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
HRH3 Q9Y5N1 5/20 0.42
SIGMAR1 Q99720 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LTA4H P09960 1/20 0.40
HRH1 P35367 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13004099 0.82 ALDH1A1 (0.45) SLC6A4HRH3TDP1MEN1KMT2A
SCHEMBL16695140 0.80 HRH3 (0.54) HRH3SIGMAR1MEN1KMT2ALTA4H
SCHEMBL19043081 0.75 HRH3 (0.59) HRH3SIGMAR1MEN1KMT2ALTA4H
SCHEMBL23732064 0.74 HTR1A (0.44) HRH3MEN1KMT2ALTA4HALDH1A1
SCHEMBL2891302 0.74 ACACB (0.41) ALDH1A1
SCHEMBL16695099 0.74 CSNK2A1 (0.54) SLC6A4SLC6A3HRH3SIGMAR1LTA4H
SCHEMBL16453525 0.72 NOS3 (0.48) MEN1KMT2ACYP1A2
SCHEMBL30786159 0.71 DRD2 (0.48) DRD2SLC6A4SLC6A3HRH3SIGMAR1
SCHEMBL21608303 0.71 CXCR4 (0.49) SIGMAR1
SCHEMBL25781852 0.71 HRH3 (0.52) DRD2SLC6A4SLC6A3HRH3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3912977-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BioMarin Pharmaceutical Inc. (US) 2021-11-24 EP disclosed
EP-3046920-B1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BIOMARIN PHARM INC (US) 2021-08-04 EP disclosed